Alnylam Pharmaceuticals
ALNY
#459
Rank
NZ$91.51 B
Marketcap
NZ$692.67
Share price
-0.28%
Change (1 day)
49.24%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company